“Type 1 Diabetes Development Requires Both CD4+ and CD8+ T Cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations ”. The Review of Diabetic Studies , vol. 6, no. 2, Aug. 2023, https://diabeticstudies.org/index.php/RDS/article/view/259.